baber/WOPTO huggingface dataset:
Patent NZ-285865-A (NZ)
Title: Work station with components like a keyboard and/or pc monitor or printer mounted pivotally on sleeves over uprights of a chair supporting base
Inventor: HOCKING RORY
IPC: A47B21/00
Filed: 1995-05-26
Abstract: PCT No. PCT/NZ95/00043 Sec. 371 Date Nov. 25, 1996 Sec. 102(e) Date Nov. 25, 1996 PCT Filed May 26, 1995 PCT Pub. No. WO95/32647 PCT Pub. Date Dec. 7, 1995A work station which includes a chair and means to support pieces of equipment such as a personal computer, a printer and the like. The station has at least two upright stanchions (4,5) which project upwardly in a substantially parallel manner from a base (6). Sleeves (e.g. 8a) are engaged on the stanchions and the sleeves can act as spacers. Support members for the pieces of equipment are attached individually or in combination to a sleeve or sleeves so the support members will extend from the sleeves in a direction substantially normal to the longitudinal axis of the stanchions. The chair is supported between the stanchions at the desired height by being attached to the sleeves which are engaged on the stanchions. The work station can also include an electrical power reticulation system, a sound system and a lighting arrangement.
Patent NZ-295245-A (NZ)
Title: Sustained release caffeine formulation comprising microparticles have a biodegradable water soluble matrix that are uniformly distributed and to a method of making it
Inventor: ENSLEN MARC Y A
IPC: A61K47/36
Filed: 1995-11-27
Abstract: The present invention relates to a composition for the controlled release of a stimulant of xanthine or a xanthine derivative, which comprises microparticles including a biodegradable matrix of at least one water-soluble material and the stimulant, said stimulant being in the form of solid particles which are substantially uniformly distributed throughout the matrix. It is also concerning a method for making this composition by dispersing the stimulant in the form of a plurality of solid particles into a biodegradable matrix. Such composition can advantageously be orally administrated for increasing the alertness of an individual.
Patent NZ-332502-A (NZ)
Title: Coordinating and controlling projectors with subscribing information mediators connected to computerised control centre for round-the-clock transmission to general public
Inventor: HYLIN MATS
IPC: G03B21/00
Filed: 1997-04-23
Abstract: The display system has projectors (22) at a number of public places, e.g. railway stations. The projectors are connected and controlled by local computers (34,38) that are linked through a communication system, e.g. radio (14), to a central computer system (10). Projectors are many places of different types can be linked to this system. Also connected to the central system are information mediators (24). These may be advertisers or any other source requiring to present public displays. The information suppliers can be allowed to directly book dispaly time slots through the central computer which then organised the distribution of the display material.
Patent NZ-335331-A (NZ)
Title: Sunscreen with diappearing color indicator
Inventor: ROSS JAMIE S
IPC: A61K8/06
Filed: 1997-11-21
Abstract: A colored, sunscreen emulsion is disclosed which employs a water-soluble dye or a blend of water-soluble dyes whose color substantially disappears when the sunscreen emulsion dries after it is spread on the skin and/or is rubbed out. The coloration in the sunscreen enables the user to more effectively protect against sunburn by allowing more complete and uniform coverage of the sunscreen on the skin. The sunscreen emulsion comprises: a) at least one water-soluble dye that imparts a color other than white to the sunscreen emulsion, such that when the sunscreen emulsion dries after it is spread on the skin and/or is rubbed out, the color substantially disappears; b) at least one sunscreen active in an amount effective to protect against the actinic radiation of the sun; c) at least one emulsfier; d) sufficient water to form the colored emulsion; e) optionally, one or more emollients, humectants, dry-feel agents, waterproofing agents, preservatives, antioxidants, chelating agents and fragrances as well as any other class of materials whose presence may be cosmetically, efficaciously or otherwise desirable.
Patent NZ-337047-A (NZ)
Title: Processes for the preparation myo-inositol phosphates
Inventor: BITTMAN ROBERT
IPC: C07F9/08
Filed: 1998-02-04
Abstract: A method of preparing 1-O-[(+)-menthoxycarbonyl]-6-O-benzyl-2,3:4,5-di-O-isopropylidene-myo-inositol which comprises: (a) converting D-myo-inositol to (+-)-2,3:4,5-di-O-isopropylidene-myo-inositol by the steps of: (i) acetonation of myo-inositol so as to give (+-)-2,3-O-isopropylidene-myo-inositol; and, (ii) acetonation of the product of step (i) so as to give to (+-)-2,3:4,5-di-O-isopropylidene-myo-inositol; (b) converting the product of step (a) to (+-)-O-6-benzyl-2,3:4,5-di-O-isopropylidene by the steps of: (i) stannylation of (+-)-2,3:4,5-di-O-isopropylidene-myo-inositol; and, (ii) benzylation of the product of step (i) so as to give (+-)-6-O-benzyl-2,3:4,5-di-O-isopropylidene-myo-inositol; (c) converting the product of step (b) to 1-O-[(+-)-menthoxycarbonyl]-6-O-benzyl-2,3:4,5-di-O-isopropylidene-myo-inositol; and, (d) isolation of 1-O-[(+)-menthoxycarbonyl]-6-O-benzyl-2,3:4,5-di-O-isopropylidene-myo-inositol from the product of step (c).
Patent NZ-504597-A (NZ)
Title: Uses of anti-ErbB2 antibodies
Inventor: HELLMANN SUSAN D
IPC: C12P21/08
Filed: 2000-05-17
Abstract: The use of a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline derivative in the preparation of a medicament for treating disorders characterized by overexpression of ErbB2 in a human patient.  The medicaments are useful in treating cancers in particular.
Patent NZ-504650-A (NZ)
Title: Non-polypeptide compounds that decrease the levels of TNF-alpha levels, increase cAMP levels and inhibit phosphodiesterase
Inventor: MULLER GEORGE W
IPC: A61P33/06
Filed: 1998-11-17
Abstract: 1-Oxo-2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and 1,3-dioxo-2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines reduce the levels of inflammatory cytokines such as tumour necrosis factor (TNF) alpha in a mammal. This knowledge is based on the discovery that derivatives of certain classes of nonpolypeptide compounds described herein decrease the levels of TNFá, increase cAMP levels and inhibit phosphodiesterase.  The method of reducing levels of TNFá and other inflammatory cytokines in a mammal through the administration of such derivatives, and pharmaceutical compositions containing such derivatives is described herein for (a) a 2- (2,6-dioxo-3-fluoropiperidin-3-yl)-isoindoline of formula (I) in which Y is oxygen or H2 and each of R', R2, R3, and R4, independently of the others, is hydrogen, halo, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, or amino, and (b) the acid addition salts of said 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines which contain a nitrogen atom capable of being protonated.
Patent NZ-506943-A (NZ)
Title: A composition that is the reaction product of a group 8 trivalent metal ion - excluding chromium, an acid phosphorous compound and an aluminium hydroxy chloride
Inventor: GUERRINI ROBERT J
IPC: C01B25/45
Filed: 1999-04-20
Abstract: Disclosed is a composition comprising the reaction product formed by the reaction of 3 to 30 parts by volume of an aqueous solution containing 40 wt% active FeCl3, 0.5 to 10 parts by volume of an aqueous solution containing about 50 wt% (Al(H2PO4)3XH2O) and 5 to 20 parts by volume of an aqueous solution containing 50 wt% Al2(OH)5Cl, wherein the reaction product has the following structure: Iron (III) salt of [Aln(OH)a(H2PO4)bClc(H20)d ]3n-a-b-b wherein a+b+c >3n; n, a, b, c and d are defined based on the relative amounts of reactants.
Patent NZ-515588-A (NZ)
Title: Uteroglobin in the treatment of IgA mediated autoimmune disorders, screening for variants and diagnosing IgA neuropathy
Inventor: MUKHERJEE ANIL
IPC: C12Q1/68
Filed: 2000-04-13
Abstract: A method of screening for a derivative, mimetic or variant of uteroglobin that prevents or treats an IgA mediated autoimmune disorder is disclosed, which comprises: providing a recombinant, non-human mammal having cells that normally express uteroglobin, wherein the cells have been altered to reduce or eliminate expression of uteroglobin, and predispose the mammal to develop the IgA mediated autoimmune disorder; administering to the mammal a test agent, to determine if the test agent interferes with development of the IgA mediated autoimmune disorder; and detecting the presence or absence of the IgA mediated autoimmune disorder in the mammal. Uteroglobin is useful for the prevention of IgA mediated diseases, such as IgA nephropathy, by preventing the deposition of IgA- Fibronectin immunocomplexes in tissues such as the renal glomeruli. Transgenic uteroglobin knockout animals, and animals in which uteroglobin-protein expression is reduced by antisense technology, also provide systems for studying IgA mediated diseases, and screening for appropriate treatments.
Patent NZ-518065-A (NZ)
Title: 2'-Substituted 1,1'-biphenyl-2-carbonamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
Inventor: BRENDEL JOACHIM
IPC: A61K31/505
Filed: 2000-09-19
Abstract: Compounds of formula (I) that are especially suitable as novel antiarrhythmic active agents, in particular for the treatment and prophylaxis of atrial arrhythmia, e.g. atrial fibrillations (AF) or atrial flutter are disclosed, wherein R(1), R(2), R(3), R(4), R(5), R(6), R(7), R(8), R(30) and R(31) are as defined in the specification and.
Patent NZ-521293-A (NZ)
Title: Zinc finger domains and methods of identifying same
Inventor: KIM JIN-SOO
IPC: C12Q1/68
Filed: 2001-02-17
Abstract: A method of identifying a zinc finger domain that recognizes a target site on a DNA comprising: a) providing cells containing a reporter construct, the construct comprising a reporter gene operably linked to a promoter, wherein the reporter gene expression is activated above a given level or inhibited below a given level when a transcription factor recognizes only the recruitment site of the promoter; b) providing a plurality of hybrid nucleic acids, each of which encodes a non-naturally occurring protein comprising (i) a transcription activation or repression domain, (ii) a DNA binding domain that recognizes the recruitment site, and (iii) a test zinc finger domain, wherein the encoded amino acid sequence of the test zinc finger domain varies among the members of the plurality; c) contacting the plurality of hybrid nucleic acids with the cells under conditions that permit at least one of the plurality of nucleic acids to enter at least one of the cells; d) maintaining the cells under conditions permitting expression of the hybrid nucleic acids in the cells; and e) identifying a cell that contains a hybrid nucleic acid of (b) and that activates an expression of the reporter gene above the given level or inhibits the expression of the reporter gene below the given level as an indication that the cell contains a hybrid nucleic acid encoding a test zinc finger domain that recognizes the target site.
Patent NZ-525230-A (NZ)
Title: Process for preparing distamycin derivatives
Inventor: CALDARELLI FRANCESCO
IPC: C07D207/42
Filed: 2001-11-07
Abstract: A process for preparing distamycin derivatives, in high yields and purity and without the need of carrying out several steps and/or isolating many intermediates that could lead to undesired by-products is disclosed. These compounds are useful in therapy as antitumor agents.
Patent NZ-525365-A (NZ)
Title: Lactam compound
Inventor: KOENIG THOMAS MITCHELL
IPC: A61K31/55
Filed: 2001-11-02
Abstract: Disclosed is the lactam compound N-(((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl))-(S)-1-amino-3-methyl-2,3,4,5-tetrahydro-2H-3-benzazepin-2-one dehydrate. Also disclosed is a process for preparing a lactam of formula I, comprising: (a) resolution of a lactam of formula (4) by crystallization as its acid addition salt, (b) coupling a compound of formula (10) with an amino-protected amino acid, to give a compound of formula (11), (c) de-protecting a compound of formula (11) to give a compound of formula (12), and (d) coupling the compound of formula (12) with a compound of formula R1CX1X2-C(O)A1, or (a2) coupling a compound of formula (1) with a compound of formula R1CX1X2-(CO)NH-CHR2-C(O)-A. The lactam compound described above is used in the manufacture of medicaments for inhibiting B-amyloid peptide release and/or its synthesis, including the treatment of Alzheimer's disease.
Patent NZ-526238-A (NZ)
Title: Abrasive wheels with workpiece vision feature
Inventor: CONLEY KAREN M
IPC: B24D7/10
Filed: 2001-11-14
Abstract: Abrasive grinding wheels having an irregular (i.e., gapped) perimeter shape and/or holes extending therethrough permit one to view the surface of a workpiece being ground in conventional surface finishing, snagging and/or weld blending operations. The grinding wheels may each include one or more gaps (312) disposed in spaced relation about the otherwise circular perimeter of the wheel. Holes (322) also may be provided in addition to, or in lieu of, the gaps, and similarly spaced equidistantly about the wheel. The gaps and/or holes may be configured in many diverse shapes. Gap and hole positions may be selected so as to retain the balance of the wheel (110, 310, 410). Advantageously, when the wheels are rotated about their axes, one is able to monitor the condition of the surface of the workpiece as it is being abraded, without removing the grinding wheel from the surface.
Patent NZ-533747-A (NZ)
Title: New benzo[a]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: KOCH MICHEL
IPC: C07D491/048
Filed: 2004-06-24
Abstract: A compound selected from those of formula (I): wherein: X and Y represent a group selected from hydrogen, halogen, hydroxy, alkoxy, nitro, cyano, alkyl, trihaloalkyl and NRaRb, wherein Ra and Rb are as defined in the description R1 represents hydrogen or alkyl R2 represents a group selected from hydrogen, alkyl, -OR''a, -NR'aR'b, -Ta-O''a, -N''a-Ta-NR'aR'b, -N''a-C(O)-TaH, -O-C(O) TaH, Ta-NR'aR'b, -NR''a-Ta-OR''a, -NR''a-Ta-CO2R''a and -N''a-C(O)-Ta-NR'aR'b, wherein R'a, R''a, R'b and Ta are as defined in the description R3 and R4 represent hydrogen or alkyl A represents a group of formula -CH(R5)CH(R6), -CH=C(R7)-, -C(R7)=CH-, -C(O)CH(R8) or -CH(R8)-C(O), wherein R5, R6, R7 and R8 are as defined in the description its isomers, N-oxides, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.
Patent NZ-535466-A (NZ)
Title: Tissue repair matrix
Inventor: YAMAMOTO RONALD K
IPC: A61F2/28
Filed: 2003-02-21
Abstract: An implantable porous, biodegradable, three-dimensionally fixed matrix has shape memory and comprises a network of water-insoluble mineralized biopolymer fibers, a drug and a water-soluble binder which is rendered insoluble by cross-linking. The shape memory maintains the porosity of the matrix for a period of greater than 14 days after implant. Preferably the biopolymer is fibrillar collagen. The matrix can be used for repairing fibrous tissue, cartilage or bone by promoting the formations of new fibrous tissue or cartilage formation.
Patent NZ-537161-A (NZ)
Title: Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
Inventor: BROOK CHRISTOPHER S
IPC: C07D209/88
Filed: 2003-06-27
Abstract: Disclosed are carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates thereof, compositions containing the aforementioned salts and/or solvates, and use of the aforementioned salts and/or solvates in the manufacture of a medicament for use in treating hypertension, congestive heart failure and angina.
Patent NZ-538552-A (NZ)
Title: Process for the preparation of 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline
Inventor: GILDAY JOHN PETER
IPC: C07D239/94
Filed: 2003-09-09
Abstract: Disclosed is a process and intermediates for the process of preparation of 7-methoxy-6-(morpholinopropoxy)-3,4-dihydroquinazolin-4-one of formula II comprising: the reduction of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile of formula III to give 2-amino-4-methoxy-5-(3-morpholinopropoxy) benzonitrile; the hydration of 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile to give 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide; and the cyclisation reaction of 2-amino-4-methoxy-5-(3-morpholinopropoxy) benzamide to give compounds of formula II. Also disclosed is a process an intermediates for the preparation of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile of formula III comprising: coupling 3-hydroxy-4methoxybenzonitrile with a 3-morpholino propane derivative as described in the specification to give a 4-methoxy-3-(3-morpholinopropoxy)benzonitrile; and the nitration of the 4-methoxy-3-(3-morpholinopropoxy)benzonitrile to give the compound of formula III. The processes disclosed are useful in the preparation of the 4-(3'-chloro-4'-fluroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline of formula I useful as an EGFR inhibitor.
Patent NZ-539376-A (NZ)
Title: Heterocyclocarboxamide derivatives
Inventor: EHRENFREUND JOSEF
IPC: A01N43/90
Filed: 2003-10-14
Abstract: Disclosed is a compound of formula (I) wherein: Het is a 5 or 6 membered heterocyclic ring containing one to three heteroatoms, each independently selected from O, N and S, provided that the ring is not 1,2,3-triazole, the ring being substituted by groups R8, R9 and R10 as defined in the specification; X is a single or double bond; Y is O, S, N(R11) or (CH12R13)(CR14R15)m(CR16R17)n; m is 0 or 1; n is 0 or 1; and R1-R20 are as defined in the specification. Compounds of the type disclosed are useful to prevent or control infestation of cultivated plants by phytopathogenic microorganisms.
Patent NZ-545335-A (NZ)
Title: New process for the synthesis of perindopril and its pharmaceutically acceptable salts
Inventor: DUBUFFET THIERRY
IPC: C07K5/06
Filed: 2004-08-27
Abstract: Disclosed is the process for the synthesis of the compound of formula (I) and its pharmaceutically acceptable salts thereof characterised in that a compound of formula (II) wherein R1 represents a hydrogen atom or a benzyl or linear or branched (C1-6)alkyl group, is reacted with a compound of formula (III) having an S configuration wherein X represents a halogen atom and R2 represents a protecting group for the amino function, in the presence of a base, to yield, after deprotection of the amino function, a compound of formula (IV) wherein R1 is as defined hereinbefore, which is reacted with a compound of formula (V) wherein G represents a chlorine, bromine or iodine atom or a p-toluenesulfonyloxy, methanesulfonyloxy of trifluoromehtansulfonyloxy group, in the presence of a base, to yield a compound of formula (VI) wherein R1 is as defined hereinbefore, which is hydrogenated in the presence of a catalyst such as palladium, platinum, rhodium or nickel to yield, after deprotection where necessary, the compound of formula (I).
Patent NZ-552789-A (NZ)
Title: Composition for promoting vascular smooth muscle relaxation
Inventor: DAVIS ADRIAN FRANCIS
IPC: A61K9/00
Filed: 2005-08-08
Abstract: Disclosed is a composition for topical application comprising glyceryl trinitrate (nitroglycerin) as a vasodilator, a mixture of water and a C1-C5 alcohol, and glycerol, wherein the alcohol makes up no more than 40% by weight of the composition. Also disclosed is the use of the composition for treating a condition susceptible to vascular smooth muscle relaxation, such as angina or erectile dysfunction. Also disclosed is a condom with the above composition applied to it.
Patent NZ-553349-A (NZ)
Title: A drive for a cutting or grinding machine
Inventor: STRATTI TROY
IPC: E02F3/24
Filed: 2005-06-10
Abstract: An excavator cutting head includes a drive unit 10 with at least one drive shaft 20, 22 driven by an electric or hydraulic drive motor 14 linked to drive the shaft and through which the shaft passes, a mount for mounting the drive unit to a linkage arm of an excavating machine, and at least two circular cutting blades 24 mounted spaced apart on the drive shaft or shafts. The envelope defined by the projection of the periphery of the cutting blades in a direction parallel to an axis of the drive shaft on which the blades are mounted contains the drive and the mount.
Patent NZ-553664-A (NZ)
Title: A plaster jointing compound
Inventor: TAYLOR BRUCE
Filed: 2007-03-07
Abstract: Disclosed is a plaster jointing compositions comprising a plaster base compound, settable and of a predetermined colour and a fluorescent material mixed with the base compound to aid in identifying the jointing compound.
Patent NZ-555907-A (NZ)
Title: Multivalent vaccines comprising recombinant viral vectors
Inventor: HAVENGA MENZO JANS EMCO
IPC: A61K35/761
Filed: 2005-11-15
Abstract: Provided is a recombinant replication-defective adenovirus comprising a nucleic acid sequence encoding two or more antigens, including at least one antigen encoded by the Ag85A open reading frame and an antigen encoded by the Ag85B open reading frame, from at least one tuberculosis (TB)-causing bacillus. Further provided is use of the recombinant virus in the manufacture of a vaccine for tuberculosis (TB)-causing bacillus.
Patent NZ-556004-A (NZ)
Title: Compositions of influenza viral proteins comprising at least one flagellin and at least one influenza M2 protein
Inventor: POWELL THOMAS J
IPC: A61K39/12
Filed: 2005-12-21
Abstract: Disclosed is a fusion protein comprising at least one flagellin or a portion thereof and at least one influenza M2 protein or a functional portion thereof. Further disclosed is a composition comprising at least one flagellin or at least a portion thereof and at least one M2 protein or a functional portion thereof.
Patent NZ-561185-A (NZ)
Title: Herd management technology
Inventor: ANDERSON MARK L
Filed: 2007-09-05
Abstract: A method of determining breeding status in animals comprising the steps of: (a) providing a first breeding detection apparatus, wherein the breeding detection apparatus shows a predetermined first colour upon activation indicative of a first breeding event; (b) affixing the first breeding detection apparatus at a predetermined location on a female animal; (c) monitoring the first breeding detection apparatus for activation thereof; (d) removing the activated first breeding detection apparatus from the female animal; (f) affixing a second breeding detection apparatus to the female animal, which upon activation has a second colour; (g) exposing the animal to a male animal for a predetermined period of time; (h) monitoring the female animal with the second breeding detection apparatus for a predetermined period of time, the activation of which is indicative of a second breeding event; and (i) further comprising the step of repeating steps (a)-(h) on each individual animal in a herd of animals including a plurality of individual animals.
Patent NZ-569226-A (NZ)
Title: Flexible forehead support
Inventor: BRAMBILLA ENRICO
IPC: A61M16/06
Filed: 2008-06-19
Abstract: A respiratory mask includes a mask frame 30 and a forehead support 20 provided to the mask frame. The forehead support includes a base 22 extending from the frame. The base includes a flexible portion along at least a portion of its length including a material and/or physical characteristic that allows the base to flex from an original, unloaded position, in form of recesses or cut-outs 26 about the perimeter of the base.